Stoke Therapeutics, Inc. STOK Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Stoke Therapeutics, Inc. (STOK) reported operating lease right-of-use assets in other assets of $2.49M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 34.9% year-over-year, from $3.83M to $2.49M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 22.7% compound annual growth rate (CAGR), from $1.12M to $3.1M.